Compare ALKS & WEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | WEX |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | Ireland | United States |
| Employees | 2050 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.1B |
| IPO Year | 2012 | 2004 |
| Metric | ALKS | WEX |
|---|---|---|
| Price | $45.24 | $188.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 15 |
| Target Price | $56.21 | ★ $195.91 |
| AVG Volume (30 Days) | ★ 1.9M | 477.6K |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.93 |
| EPS | N/A | ★ 5.33 |
| Revenue | $1,475,899,000.00 | ★ $2,660,800,000.00 |
| Revenue This Year | $23.57 | $9.15 |
| Revenue Next Year | $6.58 | $1.74 |
| P/E Ratio | ★ N/A | $34.87 |
| Revenue Growth | N/A | ★ 1.24 |
| 52 Week Low | $27.00 | $125.29 |
| 52 Week High | $55.67 | $203.99 |
| Indicator | ALKS | WEX |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 54.98 |
| Support Level | $39.41 | $183.52 |
| Resistance Level | $45.20 | $192.37 |
| Average True Range (ATR) | 1.39 | 5.35 |
| MACD | 0.62 | 1.66 |
| Stochastic Oscillator | 96.63 | 62.36 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.